LYRA THERAPEUTICS
Lyra Therapeutics, Inc. is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat diseases. The company’s proprietary technology platform, XTreo, is designed to precisely and consistently deliver medicines directly to the affected tissue for sustained periods with a single administration. The company’s initial product candidates, LYR-210 and LYR-... 220, are bioresorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver up to six months of continuous drug therapy to the sinonasal passages for the treatment of CRS. The therapeutic embedded within LYR-210 and LYR-220 is mometasone furoate, which is the active ingredient in various FDA-approved drugs and has a well-established efficacy and safety profile.
LYRA THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics Wellness
Founded:
2005-01-01
Address:
Watertown, Massachusetts, United States
Country:
United States
Website Url:
http://www.lyratherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
617.393.4600
Email Addresses:
[email protected]
Total Funding:
214.09 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics Font Awesome
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Amicus Therapeutics
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Dystrogen Therapeutics
Dystrogen Therapeutics is a clinical-stage regenerative medicine company focusing on rare diseases.
Eliem Therapeutics
Eliem Therapeutics is a clinical-stage biotechnology company developing treatments for nervous system disorders.
Keeps
Keeps is a startup aimed at preventing and slowing age-related hair loss.
Koya Medical
Koya Medical is a transformative healthcare company developing breakthrough treatments for lymphedema and venous diseases.
LifeGuides, PBC
Modernizing human support & learning - The Marketplace for Life Experience. More casual than therapy, more qualified than a friend. B2B SaaS
Lyndra Therapeutics
Lyndra Therapeutics is a novel technology platform reinventing medicine for a healthier world.
MBX Biosciences
MBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.
Medable
Medable is transforming clinical research and predictive medicine by creating a platform powered by patient generated data.
NorthSea Therapeutics
NorthSea Therapeutics is a clinical-stage biotech company developing first-in class, oral, structurally-engineered lipid therapeutics.
Nutcracker Therapeutics
Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.
OneSkin
OneSkin is a longevity company developing products designed to extend skin and body health by targeting aging at its source.
Pinpoint Therapeutics
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
Primaeva Medical
Primaeva Medical is a venture capital funded company developing devices for dermatologists, plastic surgeons and other cosmetic physicians.
Pure Scientific Technologies
Pure Scientific Technologies is a medical device startup company that develops a new patent-pending drug delivery system.
Thermaband
Thermaband is a health and wellness company empowering menopausal women with personal comfort on demand through a cooling/warming wearable.
Treadwell Therapeutics
Treadwell Therapeutics is a clinical-stage oncology company that develops medicines to address unmet needs in patients with cancer.
X4 Pharmaceuticals
X4 Pharmaceuticals a clinical-stage oncology company developing best-in-class oral small molecule CXCR4 antagonists for the treatment.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Perceptive Advisors
Perceptive Advisors investment in Post-IPO Equity - Lyra Therapeutics
Samsara BioCapital
Samsara BioCapital investment in Post-IPO Equity - Lyra Therapeutics
North Bridge Venture Partners & Growth Equity
North Bridge Venture Partners & Growth Equity investment in Post-IPO Equity - Lyra Therapeutics
Nantahala Capital Management
Nantahala Capital Management investment in Post-IPO Equity - Lyra Therapeutics
Pura Vida Investments
Pura Vida Investments investment in Post-IPO Equity - Lyra Therapeutics
Venrock Healthcare Capital Partners
Venrock Healthcare Capital Partners investment in Post-IPO Equity - Lyra Therapeutics
RA Capital Management
RA Capital Management investment in Series C - Lyra Therapeutics
Soleus Capital
Soleus Capital investment in Series C - Lyra Therapeutics
Perceptive Advisors
Perceptive Advisors investment in Series C - Lyra Therapeutics
Polaris Partners
Polaris Partners investment in Series C - Lyra Therapeutics
Key Employee Changes
Official Site Inspections
http://www.lyratherapeutics.com Semrush global rank: 4.67 M Semrush visits lastest month: 2.09 K
- Host name: 169.101.198.104.bc.googleusercontent.com
- IP address: 104.198.101.169
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Lyra Therapeutics"
Lyra Therapeutics - Lyra Therapeutics
Lyra Therapeutics is a clinical-stage biotechnology company developing innovative therapies for the localized treatment of chronic rhinosinusitis (CRS).See details»
Company - Lyra Therapeutics
Lyra Therapeutics is a clinical-stage biotechnology company developing innovative therapies for the localized treatment of chronic rhinosinusitis (CRS), an inflammatory disease of the paranasal sinuses which leads to debilitating …See details»
Leadership - Lyra Therapeutics
Harlan W. Waksal, M.D., has led several late-stage and commercial biotech and pharmaceutical companies as well as secured successful financial deals after scaling companies during more …See details»
Lyra Therapeutics - Crunchbase Company Profile
Lyra Therapeutics is a clinical-stage company developing medicines to treat ear, nose, and throat diseases. Private equity firms holding 39% of Lyra …See details»
Investor Relations - Lyra Therapeutics, Inc.
Lyra Therapeutics, Inc. is a clinical-stage biotechnology company developing long-acting, anti-inflammatory nasal inserts for the treatment of chronic rhinosinusitis (CRS).See details»
Lyra Therapeutics - LinkedIn
Lyra Therapeutics is a clinical-stage biotechnology company developing innovative therapies for the localized treatment of chronic rhinosinusitis (CRS), an inflammatory disease of the paranasal...See details»
Lyra Therapeutics - MassBio
Lyra Therapeutics, Inc. is a clinical-stage therapeutics company leveraging its proprietary XTreo™ platform to enable precise, sustained, local delivery of medications to diseased tissues not …See details»
Lyra Therapeutics, Inc. (LYRA) - Yahoo Finance Canada
Lyra Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment...See details»
Lyra Therapeutics - Craft
Aug 13, 2024 · Lyra Therapeutics (formerly known as 480 Biomedical) is a therapeutics company focused on the development of integrated drug and delivery solutions for the localized …See details»
News Release - investors.lyratherapeutics.com
Jul 12, 2021 · A live webcast of the fireside chat presentation will be available in the Investor Relations section of the Company’s website at https://investors.lyratherapeutics.com. The …See details»
For Patients - Lyra Therapeutics
Patients try multiple approaches to seek CRS symptom relief, including over-the-counter remedies, sinus rinses, and prescribed steroids delivered via nasal spray or oral pills. These approaches are not effective in relieving CRS symptoms …See details»
Lyra Therapeutics Reports First Quarter 2024 Financial Results and ...
Lyra Therapeutics, Inc. is a clinical-stage biotechnology company developing therapies for the localized treatment of patients with chronic rhinosinusitis (CRS), a highly prevalent …See details»
Lyra Therapeutics Announces Positive Topline Results from …
WATERTOWN, Mass., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company”), a clinical-stage biotechnology company developing …See details»
Technology - Lyra Therapeutics
Lyra Therapeutics’ proprietary technology is designed to enable sustained delivery of medication for up to six months of therapy per placement, targeting tissues deep in the sinonasal …See details»
Lyra Therapeutics Reports Fourth Quarter and Full Year 2022 …
Mar 29, 2023 · Lyra Therapeutics, Inc. is a clinical-stage biotechnology company developing therapies for the localized treatment of patients with chronic rhinosinusitis (CRS).See details»
Lyra Therapeutics Reports Topline Results from Phase 3 …
WATERTOWN, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company”), today announced topline results from the Company’s Phase …See details»
Lyra Therapeutics Announces First Patient Treated in Phase 2 …
Apr 25, 2022 · Lyra Therapeutics, Inc. is a clinical-stage therapeutics company leveraging its proprietary XTreo™ platform to enable precise, sustained, local delivery of medications to …See details»
Pipeline - Lyra Therapeutics
Lyra Therapeutics’ product candidates are designed to provide medicine directly to sinonasal tissues that are not accessible with conventional therapeutic approaches.See details»
Job Opportunities - Lyra Therapeutics
Lyra Therapeutics is an equal-opportunity employer, offering competitive cash and stock-based compensation, excellent employee benefits and tremendous opportunity for personal and …See details»